Novel RNA regulatory mechanisms revealed in the epitranscriptome

Por Saletore, Yogesh, Chen-Kiang, Selina, Mason, Christopher E.
Publicado em 2013

Cell Cycle Dysregulation in Mantle Cell Lymphoma Genomics and Therapy

Por Wang, Kevin, Huang, Xiangao, Di Liberto, Maurizio, Chen-Kiang, Selina
Publicado no Hematol Oncol Clin North Am (2020)

Immunomodulation by anticancer cell cycle inhibitors

Por Petroni, Giulia, Formenti, Silvia C., Chen-Kiang, Selina, Galluzzi, Lorenzo
Publicado no Nat Rev Immunol (2020)

Targeting CDK4/6 in mantle cell lymphoma

Por Lee, Christina, Huang, Xiangao, Di Liberto, Maurizio, Martin, Peter, Chen-Kiang, Selina
Publicado no Ann Lymphoma (2020)

Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response

Por Do, Richard K.G., Hatada, Eunice, Lee, Hayyoung, Tourigny, Michelle R., Hilbert, David, Chen-Kiang, Selina
Publicado em 2000

Noxa mediates p18(INK4c) cell-cycle control of homeostasis in B cells and plasma cell precursors

Por Bretz, Jamieson, Garcia, Josefina, Huang, Xiangao, Kang, Lin, Zhang, Yang, Toellner, Kai-Michael, Chen-Kiang, Selina
Publicado em 2011

A novel effect of thalidomide and its analogs: suppression of cereblon ubiquitination enhances ubiquitin ligase function

Por Liu, Yaobin, Huang, Xiangao, He, Xian, Zhou, Yanqing, Jiang, Xiaogang, Chen-Kiang, Selina, Jaffrey, Samie R., Xu, Guoqiang
Publicado no FASEB J (2015)

CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis

Por Franklin, David S., Godfrey, Virginia L., Lee, Hayyoung, Kovalev, Grigoriy I., Schoonhoven, Robert, Chen-Kiang, Selina, Su, Lishan, Xiong, Yue
Publicado em 1998

Investigation of antitumor effects of synthetic epothilone analogs in human myeloma models in vitro and in vivo

Por Wu, Kai-Da, Cho, Young Shin, Katz, Jonathan, Ponomarev, Vladimir, Chen-Kiang, Selina, Danishefsky, Samuel J., Moore, Malcolm A. S.
Publicado em 2005

Phase II trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma

Por Niesvizky, Ruben, Ely, Scott, Mark, Tomer, Aggarwal, Sangeeta, Gabrilove, Janice L., Wright, John J., Chen-Kiang, Selina, Sparano, Joseph A.
Publicado em 2010

BiRd (clarithromycin, lenalidomide, dexamethasone): an update on long-term lenalidomide therapy in previously untreated patients with multiple myeloma

Por Rossi, Adriana, Mark, Tomer, Jayabalan, David, Christos, Paul, Zafar, Faiza, Pekle, Karen, Pearse, Roger, Chen-Kiang, Selina, Coleman, Morton, Niesvizky, Ruben
Publicado em 2013

Disruption Of MYC-MiRNA-EZH2 Loop To Suppress Aggressive B-Cell Lymphoma Survival And Clonogenicity

Por Zhao, Xiaohong, Lwin, Tint, Zhang, Xinwei, Huang, Andy, Wang, Jian, Marquez, Victor E., Chen-Kiang, Selina, Dalton, William S., Sotomayor, Eduardo, Tao, Jianguo
Publicado em 2013

CDK4/6 inhibitor PD 0332991 sensitizes acute myeloid leukemia to cytarabine-mediated cytotoxicity

Por Yang, Chenyi, Boyson, Cynthia A., Di Liberto, Maurizio, Huang, Xiangao, Hannah, Jeffrey, Dorn, David C., Moore, Malcolm AS, Chen-Kiang, Selina, Zhou, Pengbo
Publicado no Cancer Res (2015)

Induction of prolonged early G(1) arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1

Por Chiron, David, Martin, Peter, Di Liberto, Maurizio, Huang, Xiangao, Ely, Scott, Lannutti, Brian J., Leonard, John P., Mason, Christopher E., Chen-Kiang, Selina
Publicado em 2013

CCMCL1: a new model of aggressive mantle cell lymphoma

Por Zhao, Xiaoxian, Chen-Kiang, Selina, Shetty, Shashirekha, Di Liberto, Maurizio, Bodo, Juraj, Durkin, Lisa, Eng, Ken, Elemento, Olivier, Smith, Mitchell R., Hsi, Eric D.
Publicado no Blood (2015)

Homeostatic cell-cycle control by BLyS: Induction of cell-cycle entry but not G(1)/S transition in opposition to p18(INK4c) and p27(Kip1)

Por Huang, Xiangao, Di Liberto, Maurizio, Cunningham, Adam F., Kang, Lin, Cheng, Shuhua, Ely, Scott, Liou, Hsiou-chi, MacLennan, Ian C. M., Chen-Kiang, Selina
Publicado em 2004

Cellular immune responses against CT7 (MAGE-C1) and humoral responses against other cancer-testis antigens in multiple myeloma patients

Por Lendvai, Nikoletta, Gnjatic, Sacha, Ritter, Erika, Mangone, Michael, Austin, Wayne, Reyner, Karina, Jayabalan, David, Niesvizky, Ruben, Jagannath, Sundar, Bhardwaj, Nina, Chen-Kiang, Selina, Old, Lloyd J., Cho, Hearn Jay
Publicado em 2010

Therapeutic Targeting of the Cyclin D3:CDK4/6 Complex in T Cell Leukemia

Por Sawai, Catherine, Freund, Jacquelyn, Oh, Philmo, Ndiaye-Lobry, Delphine, Bretz, Jamieson C., Strikoudis, Alexandros, Genesca, Lali, Trimarchi, Thomas, Kelliher, Michelle A., Clark, Marcus, Soulier, Jean, Chen-Kiang, Selina, Aifantis, Iannis
Publicado em 2012

A phase 1 trial of ibrutinib plus palbociclib in previously treated mantle cell lymphoma

Por Martin, Peter, Bartlett, Nancy L., Blum, Kristie A., Park, Steven, Maddocks, Kami, Ruan, Jia, Ridling, LeAnn, Dittus, Christopher, Chen, Zhengming, Huang, Xiangao, Inghirami, Giorgio, DiLiberto, Maurizio, Chen-Kiang, Selina, Leonard, John P.
Publicado no Blood (2019)

Prolonged early G(1) arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle–coupled loss of IRF4

Por Huang, Xiangao, Di Liberto, Maurizio, Jayabalan, David, Liang, Jun, Ely, Scott, Bretz, Jamieson, Shaffer, Arthur L., Louie, Tracey, Chen, Isan, Randolph, Sophia, Hahn, William C., Staudt, Louis M., Niesvizky, Ruben, Moore, Malcolm A. S., Chen-Kiang, Selina
Publicado em 2012